£114.88

It has never been this cheap. We have no record of a lower price.

£115 today · cheaper than every other day in the last 3 months

Springer Molecular Vaccines: From Prophylaxis to Therapy - Volume 2

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical
Generating forecast…
£114.88 £109.14 £111.43 £113.73 £116.03 £118.33 £120.62 11 August 2026 29 August 2026 17 September 2026 06 October 2026 25 October 2026
View at Amazon ↗

Price data last checked 15 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 76 days • 1 price levels

Days at Price
76 days 0 19 38 57 76 £115 Days at Price

Price Analysis

Most common price: £115 (76 days, 100.0%)

Price range: £115 - £115

Price levels: 1 different prices over 76 days

Description

This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application. From the Back Cover This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Practical perspectives of patentability of vaccines are discussed. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application. About the Author Dr. Matthias Giese, Heidelberg, Germany

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Vaccine Protocols: 87 (Methods in Molecular Medicine, 87)
81% match

Vaccine Protocols: 87 (Methods in Molecular Medicine, 87)

Humana

£112.39 24 Oct 2026
Development of Novel Vaccines: Skills, Knowledge and Translational Technologies
81% match

Development of Novel Vaccines: Skills, Knowledge and Translational Technologies

Springer

£110.36 23 Oct 2026
Vaccine Adjuvants: Methods and Protocols: 626 (Methods in Molecular Biology, 626)
80% match

Vaccine Adjuvants: Methods and Protocols: 626 (Methods in Molecular Biology, 626)

Humana

£73.14 22 Oct 2026
The Clinician’s Vaccine Safety Resource Guide: Optimizing Prevention of Vaccine-Preventable Diseases Across the Lifespan
79% match

The Clinician’s Vaccine Safety Resource Guide: Optimizing Prevention of Vaccine-Preventable Diseases Across the Lifespan

Springer

£74.21 24 Aug 2026
DNA Vaccines: Methods and Protocols: 1143 (Methods in Molecular Biology, 1143)
79% match

DNA Vaccines: Methods and Protocols: 1143 (Methods in Molecular Biology, 1143)

Humana

£80.67 23 Oct 2026
Vaccines against Allergies: 352 (Current Topics in Microbiology and Immunology, 352)
78% match

Vaccines against Allergies: 352 (Current Topics in Microbiology and Immunology, 352)

Springer

£108.01 22 Oct 2026
Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols: 1349 (Methods in Molecular Biology, 1349)
78% match

Vaccine Technologies for Veterinary Viral Diseases: Methods and Protocols: 1349 (Methods in Molecular Biology, 1349)

Humana

£73.14 21 Oct 2026
DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)
78% match

DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases (RNA Technologies)

Springer

£114.88 22 Oct 2026
Microbial Nanobionics: Volume 2, Basic Research and Applications (Nanotechnology in the Life Sciences)
77% match

Microbial Nanobionics: Volume 2, Basic Research and Applications (Nanotechnology in the Life Sciences)

Springer

£109.16 24 Oct 2026
Nanomedicine (Advances in Delivery Science and Technology)
77% match

Nanomedicine (Advances in Delivery Science and Technology)

Springer

£114.71 22 Oct 2026
Applications of Nanomaterials in Human Health
77% match

Applications of Nanomaterials in Human Health

Springer

£110.46 26 Oct 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
77% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 22 Oct 2026
77% match

Molecular and Cellular Biology Approaches and Applications in Modern Drug Discovery

Elsevier

£157.99 22 Oct 2026
Nanoformulations in Human Health: Challenges and Approaches
77% match

Nanoformulations in Human Health: Challenges and Approaches

Springer

£104.35 16 Oct 2026
Drug Product Development for the Back of the Eye: 2 (AAPS Advances in the Pharmaceutical Sciences Series, 2)
77% match

Drug Product Development for the Back of the Eye: 2 (AAPS Advances in the Pharmaceutical Sciences Series, 2)

Springer

£147.56 23 Oct 2026
Development of Vaccines: From Discovery to Clinical Testing
77% match

Development of Vaccines: From Discovery to Clinical Testing

Wiley

£132.95 23 Oct 2026
Antibody Engineering Volume 2 (Springer Protocols Handbooks)
77% match

Antibody Engineering Volume 2 (Springer Protocols Handbooks)

Springer

£219.99 09 Sep 2026
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
77% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£108.78 22 Oct 2026
Characterization of Nanoparticles Intended for Drug Delivery: 1682 (Methods in Molecular Biology, 1682)
77% match

Characterization of Nanoparticles Intended for Drug Delivery: 1682 (Methods in Molecular Biology, 1682)

Humana

£80.67 24 Oct 2026
Nanomedicine (Advances in Delivery Science and Technology)
77% match

Nanomedicine (Advances in Delivery Science and Technology)

Springer

£112.84 23 Oct 2026
Biomedical Nanotechnology: Methods and Protocols: 1570 (Methods in Molecular Biology, 1570)
77% match

Biomedical Nanotechnology: Methods and Protocols: 1570 (Methods in Molecular Biology, 1570)

Humana

£73.14 22 Oct 2026
Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View
77% match

Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View

Springer

£114.71 23 Oct 2026
Nanotechnology Theranostics in Livestock Diseases and Management
77% match

Nanotechnology Theranostics in Livestock Diseases and Management

Springer

£153.09 22 Oct 2026
Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention: 2025 (Advanced Bio-Medical CRISPR Technologies)
77% match

Cancer Vaccines - Harnessing Immunotherapy and Genetic Engineering for Universal Cancer Prevention: 2025 (Advanced Bio-Medical CRISPR Technologies)

£55.54 14 Sep 2026